Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
U.S. Assistance to Foreign Military and Security Forces: Roles of the Departments of State and Defense
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 

Available Options:
Special Focus Titles
01.Chinese Civilization in the 21st Century
02.Conflict and Communication: A Changing Asia in a Globalizing World - Social and Political Perspectives
03.True Islam, Jihad, and Terrorism: The Science of Islamic Foreign Policy
04.The Family Doctors: Images and Metaphors of the Family Doctor to Learn Family Medicine
05.International Book of Erectile Dysfunction
06.Post-Acute and Long Term Geriatric Care Clinical Advisor. Volume II
07.Intelligent Tutoring Systems: Structure, Applications and Challenges
08.Knowledge Creation: Going Beyond Published Financial Information
09.Theory of the Integer and Fractional Quantum Hall Effects
10.Geographic Distribution, Ecological Impact, and Conservation Strategies for North American Crayfish
11.Occurrences, Structure, Biosynthesis, and Health Benefits Based on Their Evidences of Medicinal Phytochemicals in Vegetables and Fruits. Volume 6
12.Innovative Bio-Products for Agriculture: Pig Manure Utilization and Treatment

Nova Science Publishers
© Copyright 2004 - 2016

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266